Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.059 | 0.2 |
mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |
mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.3 |
mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.06 | 0.3 |
mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.3 |